Letter: Treatment of vulval candidiasis with 5-fluorocytosine.
D000935:Antifungal Agents / Q000627:therapeutic use*; D002175:Candida / Q000187:drug effects / Q000302:isolation & purification; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D003596:Cytosine / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005243:Feces / Q000382:microbiology; D005260:Female; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use
D000935:Antifungal Agents; D007093:Imidazoles; D003596:Cytosine; D005437:Flucytosine